Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
3.050
-0.050 (-1.61%)
At close: Aug 10, 2026, 4:00 PM EDT
3.330
+0.280 (9.18%)
After-hours: Aug 10, 2026, 7:08 PM EDT
Evaxion Market Cap
Evaxion has a market cap or net worth of $25.44 million as of August 10, 2026. Its market cap has increased by 42.30% in one year.
Market Cap
25.44M
Enterprise Value
7.00M
1-Year Change
42.30%
Ranking
Category
Stock Price
$3.05
ChartMarket Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $25.44M, a decrease of -86.75%. That is a compound annual growth rate of -30.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 25.44M | -36.06% |
| Dec 31, 2025 | 39.78M | 702.21% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CEL-SCI | 30.06M |
| Quince Therapeutics | 29.53M |
| Kyntra Bio | 29.43M |
| Tevogen | 27.30M |
| Actuate Therapeutics | 26.44M |
| ABVC BioPharma | 25.78M |
| IGC Pharma | 25.68M |
| Actinium Pharmaceuticals | 25.02M |